Physiologically based pharmacokinetic modelling

Physiologically based pharmacokinetic (PBPK) modelling is a computational approach that predicts how drugs move through the body by simulating the actual anatomy and physiology of humans and animals. Instead of treating the body as a simple black box, PBPK models divide it into specific organs and tissues, tracking how a drug is absorbed, distributed, metabolized, and eliminated from each compartment. These mathematical models incorporate real biological parameters like organ blood flow rates, tissue volumes, and enzyme activity to create a detailed map of a drug's journey through the body. The result is a powerful tool for understanding and predicting drug concentrations in blood and tissues over time.

PBPK modelling is widely used in pharmaceutical development, toxicology, regulatory science, and clinical medicine, with applications extending to environmental health and chemical safety assessment. Regulatory agencies like the FDA and EMA increasingly accept PBPK models to support drug approval decisions, reduce the need for animal testing, and guide dosing strategies. This concept matters because it can predict how drugs behave in different patient populations—such as children, elderly individuals, or those with liver disease—without requiring numerous clinical trials, ultimately saving time and resources while improving drug safety.

The core mechanism works like a sophisticated plumbing system: instead of assuming a drug instantly disperses throughout the body, PBPK models track how much enters the lungs (if inhaled), the gut (if swallowed), or the bloodstream (if injected), then follows it as it flows through the circulatory system to various organs. Each organ is modeled with its own blood flow rate and capacity to take up and metabolize the drug, much like water flowing through interconnected pipes with different sizes and filters. The model uses differential equations to calculate how drug concentrations change moment by moment in the blood and each tissue compartment, creating a dynamic, realistic picture of what's happening inside the body.

PBPK modelling is increasingly important for personalizing medicine, predicting rare adverse effects, and addressing drug-drug interactions that might only emerge in specific patient subgroups. This technology is particularly valuable in the era of precision medicine, where understanding inter-individual variability in drug response is critical, and it continues to reshape how new drugs are developed, tested, and brought safely to patients.